Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Daniel

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Anti-Cancer Drugs|September 11, 2009
Preclinical assessment of cisplatin-based therapy versus docetaxel-based therapy on a panel of human non-small-cell lung cancer xenograftsFariba Némati, Rui Bras-Gonçalves, Jean-Jacques Fontaine, et al.
Stem Cell Reports|December 16, 2014
A flexible reporter system for direct observation and isolation of cancer stem cellsBinwu Tang, Asaf Raviv, Dominic Esposito, et al.
Lung Cancer (Amsterdam, Netherlands)|July 13, 2023
Accelerated subsequent lung cancer after post-operative radiotherapy for breast cancerClémence Basse, Julien Ancel, Marie-Ange Massiani, et al.
International Journal of Mental Health Nursing|January 8, 2026
Resistant Insistent Persistent: A Global Call by Mental Health Nursing LeadersRhonda L Wilson, Frederik Alkier Gildberg, Tanya Park, et al.
Journal of Psychiatric and Mental Health Nursing|December 12, 2025
Beyond Resilience: Resources, Respect and Recognition in Global Universal Mental Health Nursing ReformRhonda Wilson, Frederik Alkier Gildberg, Tanya Park, et al.
European Journal of Cancer (Oxford, England : 1990)|November 23, 2025
The rechallenge benefit score: A clinical decision tool for patients progressing after immunotherapyCaroline Plazy, Mohamed Boussena, Linh Nguyen Phuong, et al.
Lung Cancer (Amsterdam, Netherlands)|July 7, 2024
Real-World efficacy and safety of combination nivolumab plus ipilimumab for Untreated, Unresectable, pleural Mesothelioma: The Meso-Immune (GFPC 04-2021) trialOlivier Bylicki, Florian Guisier, Arnaud Scherpereel, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Real-life efficacy of osimertinib in pretreated patients with advanced non-small cell lung cancer harboring EGFR T790M mutationJean Bernard Auliac, Maurice Pérol, David Planchard, et al.
Clinical Lung Cancer|September 14, 2025
Rebiopsy Feasibility and Clinical Impact on Metastatic Non-Small-Cell Lung Cancer With EGFR/ALK/ROS Oncogenic Driver Progression After Optimal Targeted Therapy: A Multicenter Real-World AnalysisAntoine Bronstein, Hubert Curcio, Isabelle Monnet, et al.
Lung Cancer (Amsterdam, Netherlands)|October 3, 2025
Real-world efficacy and safety of amivantamab in EGFR exon-20-mutant non-small cell lung cancer in a French early-access program: Amexon 20 GFPC studyThomas Pierret, Laurent Greillier, Florian Guisier, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Anti-Cancer Drugs|September 11, 2009
Preclinical assessment of cisplatin-based therapy versus docetaxel-based therapy on a panel of human non-small-cell lung cancer xenograftsFariba Némati, Rui Bras-Gonçalves, Jean-Jacques Fontaine, et al.
Stem Cell Reports|December 16, 2014
A flexible reporter system for direct observation and isolation of cancer stem cellsBinwu Tang, Asaf Raviv, Dominic Esposito, et al.
Lung Cancer (Amsterdam, Netherlands)|July 13, 2023
Accelerated subsequent lung cancer after post-operative radiotherapy for breast cancerClémence Basse, Julien Ancel, Marie-Ange Massiani, et al.
International Journal of Mental Health Nursing|January 8, 2026
Resistant Insistent Persistent: A Global Call by Mental Health Nursing LeadersRhonda L Wilson, Frederik Alkier Gildberg, Tanya Park, et al.
Journal of Psychiatric and Mental Health Nursing|December 12, 2025
Beyond Resilience: Resources, Respect and Recognition in Global Universal Mental Health Nursing ReformRhonda Wilson, Frederik Alkier Gildberg, Tanya Park, et al.
European Journal of Cancer (Oxford, England : 1990)|November 23, 2025
The rechallenge benefit score: A clinical decision tool for patients progressing after immunotherapyCaroline Plazy, Mohamed Boussena, Linh Nguyen Phuong, et al.
Lung Cancer (Amsterdam, Netherlands)|July 7, 2024
Real-World efficacy and safety of combination nivolumab plus ipilimumab for Untreated, Unresectable, pleural Mesothelioma: The Meso-Immune (GFPC 04-2021) trialOlivier Bylicki, Florian Guisier, Arnaud Scherpereel, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Real-life efficacy of osimertinib in pretreated patients with advanced non-small cell lung cancer harboring EGFR T790M mutationJean Bernard Auliac, Maurice Pérol, David Planchard, et al.
Clinical Lung Cancer|September 14, 2025
Rebiopsy Feasibility and Clinical Impact on Metastatic Non-Small-Cell Lung Cancer With EGFR/ALK/ROS Oncogenic Driver Progression After Optimal Targeted Therapy: A Multicenter Real-World AnalysisAntoine Bronstein, Hubert Curcio, Isabelle Monnet, et al.
Lung Cancer (Amsterdam, Netherlands)|October 3, 2025
Real-world efficacy and safety of amivantamab in EGFR exon-20-mutant non-small cell lung cancer in a French early-access program: Amexon 20 GFPC studyThomas Pierret, Laurent Greillier, Florian Guisier, et al.
Pageof 9